Treatment of adults with attention-deficit/hyperactivity disorder - Wikidata - awgldk - TriplyDB

Treatment of adults with attention-deficit/hyperactivity disorder

Treatment of adults with attention-deficit/hyperactivity disorder

http://www.wikidata.org/entity/Q24642937

about

A randomized, double-blind, cross-over, phase IV trial of oros-methylphenidate (CONCERTA(®)) and generic novo-methylphenidate ER-C (NOVO-generic)Prior methylphenidate self-administration alters the subsequent reinforcing effects of methamphetamine in rats.Preferences related to attention-deficit/hyperactivity disorder and its treatment.Adolescent rat circadian activity is modulated by psychostimulants Mapping the effects of drugs on the immune system.Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine.A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.Adult ADHD and comorbid depression: A consensus-derived diagnostic algorithm for ADHD Real-World Dosing Patterns of Atomoxetine in Adults with Attention-Deficit/Hyperactivity Disorder Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride.A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities.Disrupted in schizophrenia 1 modulates medial prefrontal cortex pyramidal neuron activity through cAMP regulation of transient receptor potential C and small-conductance K+ channels.Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling?

P2860

Q26779556-DE827123-F291-4F4A-ADEE-305AD8D6A7C9 Q34437708-64B849A8-061F-490E-B954-8530A627E419 Q34554897-FBE8E955-603E-49D0-8563-8D67973FAB20 Q35734107-36CD0428-1D0E-44A1-8257-C39A273A64CF Q36446799-5F53EA63-287B-4358-8542-64DF8846240D Q36757388-4D87F62A-D5DB-4D1B-8278-AB110B86FEAE Q37190656-646C1D88-3845-4329-8AF3-367E0861DE06 Q37224553-AB9F43BF-5EEB-45A8-9751-02828B5FA470 Q37308847-D34572F7-19E4-4A59-B3C6-407CC024BEAB Q37318744-B198700F-6235-4611-B2FD-8FE055702310 Q37638740-E550DDF9-72F8-4769-8854-26B54D4E0858 Q42027335-CFD43BCF-3FB8-4CCF-9F14-FD824E928DB8 Q50155852-C6893D20-E9F7-4497-B01A-A4510F411372

P2860

Treatment of adults with attention-deficit/hyperactivity disorder

http://www.wikidata.org/entity/Q24642937

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Treatment of adults with attention-deficit/hyperactivity disorder

@ast

Treatment of adults with attention-deficit/hyperactivity disorder

@en

Treatment of adults with attention-deficit/hyperactivity disorder

@nl

type

label

Treatment of adults with attention-deficit/hyperactivity disorder

@ast

Treatment of adults with attention-deficit/hyperactivity disorder

@en

Treatment of adults with attention-deficit/hyperactivity disorder

@nl

prefLabel

Treatment of adults with attention-deficit/hyperactivity disorder

@ast

Treatment of adults with attention-deficit/hyperactivity disorder

@en

Treatment of adults with attention-deficit/hyperactivity disorder

@nl

P1433

Q24642937-26BD7334-F33A-4E1C-99BA-0FB20A0944EE

P1476

Q24642937-9C01F882-DF4C-4E64-973B-A6F96A87081F

P2093

Q24642937-29CE8BB4-0843-467B-9903-F64C289C69A7

Q24642937-2F672672-BF3E-4E87-9CA1-CA54D610EB1D

Q24642937-88B99B75-F5F9-4012-9882-090B83A1C99E

Q24642937-AD4F5454-2D45-49AA-8220-237F84516722

Q24642937-B678555F-4F8E-4773-86DF-5839AE0CF9DD

Q24642937-D564438B-F08A-4646-BD1A-0985E2F3ACC1

P2860

Q24642937-07CEEA5F-E71C-4761-A4CA-18E297846C63

Q24642937-081E0698-176B-4531-8D08-2A4882EF46A7

Q24642937-09C410D5-2DE0-42E6-9C9B-1C7098F104E3

Q24642937-0AA52FC3-1B5C-4C3A-A34D-4054CBCBAD41

Q24642937-1439629E-81F7-43A8-8676-D296B76A4C3A

Q24642937-1DE90593-AB5A-4EEE-8093-6015CE6EAC83

Q24642937-2718A0A7-0C34-41E2-AF3A-31F630B7770C

Q24642937-287E50A0-7B95-4038-859C-6E7CF17B21BA

Q24642937-31BE6B38-7F40-4A24-A6BA-2437F52E38FD

Q24642937-3896D485-8485-4216-AD51-AF7E1674A698

P304

Q24642937-EE63F7C1-0197-47B3-83B1-F9B3986FEB97

P31

Q24642937-1b8e0928-6e1d-4507-a611-3cd4d656def7

Q24642937-2D3920F7-EDFE-463A-9F0D-2B0A6A82777D

P3181

Q24642937-22A05E62-C0E6-44B9-AA50-26EEDAB6F1F5

P356

Q24642937-4308746E-71C3-4373-8833-E56C7E15A8A6

P407

Q24642937-DB4FD549-00F3-4BFF-824C-217569B47CA2

P433

Q24642937-7827F5A9-E019-46C3-ADC1-7F0585C23E03

P478

Q24642937-A3EC28CD-F0D5-4FA8-9D56-DA0D68DABAAC

P577

Q24642937-3C3CE739-F5D4-4D05-8464-C24AC1964EF9

P698

Q24642937-BF8058BA-8B3B-4D3A-866C-73FDB32D230A

P921

Q24642937-15936521-81D2-41D7-B26B-02D72F104802

Q24642937-E4E9EC02-9180-47DA-8E76-24B8E14A552C

P932

Q24642937-6BA2F9B2-A0AD-40C3-9131-3ECD71AF6EEB

P3181

P356

P1433

Neuropsychiatric Disease and Treatment

P1476

Treatment of adults with attention-deficit/hyperactivity disorder

@en

P2093

Amanda Keller

http://www.w3.org/2001/XMLSchema#string

Cassidy Syer

http://www.w3.org/2001/XMLSchema#string

Dusan Kolar

http://www.w3.org/2001/XMLSchema#string

Lily Hechtman

http://www.w3.org/2001/XMLSchema#string

Lucy Cumyn

http://www.w3.org/2001/XMLSchema#string

Maria Golfinopoulos

http://www.w3.org/2001/XMLSchema#string

P2860

Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms

15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder.

Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review

The marital and family functioning of adults with ADHD and their spouses.

A review of the use of modafinil for attention-deficit hyperactivity disorder.

The worldwide prevalence of ADHD: is it an American condition?

A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder.

A conceptual model of child psychopathology: implications for understanding attention deficit hyperactivity disorder and treatment efficacy.

P304

389-403

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1528207

http://www.w3.org/2001/XMLSchema#string

P356

10.2147/NDT.S6985

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18728745

http://www.w3.org/2001/XMLSchema#string

P921

attention deficit hyperactivity disorder

P932

2518387

http://www.w3.org/2001/XMLSchema#string